Амлодипин в лечении хронической сердечной недостаточности

1. Elkayam U, Amin J, Mehra A et al. A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. Circulation 1990; 82: 1954–61.
2. Barjon JN, Rouleau J-L, Bichet D et al. Chronic renal and neurohumoral effects of the calcium entry blocker nisoldipine in patients with congestive heart failure. J Am Coll Cardiol 1987; 9: 622–30.
3. Goldstein RE, Boccuzzi SJ, Cruess D. Adverse Experience Committee, Multicenter Diltiazem Postinfarction Research Group. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. Circulation 1991; 83: 52–60.
4. The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988; 319: 385–92.
5. Packer M, Kessler PD, Lee WH. Calcium-channel blockade in the management of severe chronic congestive heart failure: a bridge too far. Circulation 1987; 75 (Suppl. V): V56–64.
6. Packer M, Nicod P, Khandheria BR et al. Randomized, multicenter, double-blind, placebo-controlled evaluation of amlodipine in patients with mild-to-moderate heart failure. J Am Coll Cardiol 1991; 17 (Suppl. A): 274A.
7. Smith WB, DeAbate AC, Gollub SB et al. Beneficial long-term hemodynamic and clinical effects of amlodipine in chronic heart failure: results of a multicenter randomized, double-blind, placebo-controlled, dose-ranging study. Circulation 1994; 90 (Suppl.): I–603.
8. Levy D, Larson M, Vasan R et al. The progression from hypertension to congestive heart failure. JAMA 1996; 275: 1557–662.
9. Chen YT, Vaccarino V, Williams CS et al. Risk factors for heart failure in the elderly: a prospective community based study. Am J Med 1999; 106: 605–9.
10. Hoffman R, Psaty BM, Kronmal RA. Modifiable risk factors for incidence of heart failure in the Coronary Artery Surgery Study. Arch Intern Med 1994; 154: 417–24.
11. Jessup M, Pina I. Is it important to examine gender differences in the epidemiology and outcome of severe heart failure? J Thorac Cardiovasc Surg 2004; 127: 1247–52.
12. Weinberg E, Thienelt C, Katz S et al. Gender differences in molecular remodeling in pressure overload hypertrophy. J Am Coll Cardiol 1999; 34: 264–73.
13. Pfeffer J, Pfeffer M, Fletcher P et al. Favorable effects of therapy on cardiac performance in spontaneously hypertensive rats. Am J Physiol 1982; 242: H776–84.
14. Carroll J, Carroll E, Feldman T et al. Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation 1992; 86: 1099–107.
15. Aurigemma G, Gaasch W. Gender differences in older patients with pressure-overload hypertrophy of the left ventricle. Cardiology 1995; 86: 310–7.
16. Mendez L, Davidoff R, Cupples L et al. Congestive heart failure in patients with coronary artery disease: the gender paradox. Am Heart J 1997; 134: 207–12.
17. Krumholz H, Larson M, Levy D. Sex differences in cardiac adaptation to isolated systolic hypertension. Am J Cardiol 1993; 72: 310–3.
18. Packer M, Lee WH, Medina N et al. Prognostic importance of the immediate hemodynamic response to nifedipine in patients with severe left ventricular dysfunction. J Am Coll Cardiol 1987; 10: 1303–11.
19.Witchitz S, Haiat R, Tarrade T et al. Accidents cardio-vasculaires au cours des traitements par le verapamil: a propos de 6 observations. Nouv Press Med 1975; 4: 337–8.
20. Elkayam U, Weber L, McKay C et al. Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure. Am J Cardiol 1985; 56: 560–6.
21. Packer M, Lee WH, Medina N, Yushak M. Comparative negative inotropic effects of nifedipine and diltiazem in patients with severe left ventricular dysfunction. Circulation 1985; 72 (Suppl. III): III–275.
22. Ferlinz J, Gallo CT. Responses of patients in heart failure to long-term oral verapamil administration. Circulation 1984; 70 (Suppl. II): II–305.
23. Kloner R, Sowers J, DiBona G et al. Sex- and age-related antihypertensive effects of amlodipine. Am J Cardiol 1996; 77: 713–22.
24. Packer M, O`Connor C, Ghali J et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 1996; 335: 1107–14.
25. Национальные рекомендации ВНОК и ОССН по диагностике и лечению ХСН (третий пересмотр). Доступно на http://medic.ossn.ru/upload/ossn_pdf/Recomend/Guidelines%20SSHF%20rev.3.01%202010.pdf

С.Н.Терещенко, И.В.Жиров*

ФГУ РКНПК Минздравсоцразвития РФ, Москва
*izhirov@mail.ru

________________________________________________

S.N.Tereshchenko, I.V.Zhirov*

Russian Cardiology Research-and-Production Complex, Ministry of Health and Social Development of the Russian Federation, Moscow
*izhirov@mail.ru